SP1 and melanoma: Due to the heterogeneity of different tumors, JWA mainly inhibits the formation of blood vessels in melanoma by down-regulating the integrin-linked kinase (ILK) signaling pathway through suppressing intergrin αvβ3 and transcription factor SP1 expression (Figure 3B).